Fund one – 匯力資本股份有限公司

林羣 Andrew Lin
董事長 / 管理合夥人

林羣先生在生物科技、資產管理、資本市場和公司治理等領域有近40年的經驗。他是宜蘊生醫、台睿生技和全福生技的董事長，在生物科技方面有豐富經驗。曾擔任過美時化學製藥和蓮見國際生技的高階職位。

在資本市場，他曾是麥格理資本大中國區的總裁，在2008年至2009年間成為香港上市承銷的首位。在資產管理方面，他是香港賽富高鵬私募基金的資深合夥人，也曾在荷銀投資管理、藍天投資和源泰投資擔任高階職位。

林羣先生在多家上市櫃公司擔任高階職務，包括董事長、執行長、總經理等，並擔任多家公司的董事會成員，如富邦人壽、中美冠科、晶元光電、建興電子、閎暉實業和104人力銀行。

經歷

全福生技董事長
宜蘊生醫董事長
台睿生技董事長
富邦人壽獨立董事
宏碁智新獨立董事
前美時製藥董事長
前光寶科技集團總財務長
前麥格理資本大中國區總裁

學歷

芝加哥大學MBA
麻省電機與電腦工程碩士

魏寶生 Mark Wei
資深合夥人

魏寶生先生有40年工作經驗。他從經濟部駐外商務人員開始，後成財政部證券管理委員會科長，負責資產管理和外資開放。後來，擔任證券暨期貨管理委員會的國際組和證券發行組組長，對台灣資本市場法規相當熟悉。

1999年調至財政部保險司副司長，後成金管會保險局首任局長，共6年。他解決了壽險公司的利差損危機，推動了保險業海外投資和新保險商品。

2004年，成為首位以保險業獲得美國艾森豪獎金台灣得主。

2005年，加入AIG台灣，擔任董事長，協助公司併購中央產險，使AIG成為當時最大的外商。

2010年，加入凱基證券擔任董事長，成功輔導多家生技公司上市，後參與了凱基銀行的成立，致力於金融科技的發展，為台灣金融業帶來新動力。

經歷

新光金控董事長
新光人壽董事長
先知生技董事
新唐科技獨立董事
凱基銀行董事長
凱基證券董事長
AIG美亞產險董事長/總經理
金管會保險局局長
保險事業發展中心總經理

學歷

華盛頓大學國際企業管理碩士
交通大學海洋運輸學士

程淑芬 Sophia Cheng
資深合夥人

程淑芬女士現任國泰金控投資長，負責制定國泰集團的投資和經營策略。她曾在美林環球投顧擔任董事長，負責台灣區研究部和國內金控高階管理。擁有近三十年的資本市場實務經驗，專注於金融業營運策略，並推動金融市場改革。她在銀行、證券和保險業的研究方面享有盛譽，受到國際投資人和政府的重視。

程淑芬女士積極推動國泰金控參與國際氣候變遷相關組織和倡議活動，目前擔任亞洲投資人氣候變遷聯盟主席，推動亞洲機構投資人關注氣候變遷議題。她多年來致力於企業永續發展，貢獻卓著。2019年被授予「亞洲頂尖永續超級女性」獎項，並入選「2021年全球50位資產管理頂尖女性」。2022年獲頒「台灣永續傑出人物獎」。

經歷

國泰金控投資長
全福生技董事
先知生技董事
先驅生技董事
行政院政務顧問
國家發展委員會諮詢委員
台灣併購與私募股權協會理事
台灣影響力投資協會理事
亞洲投資人氣候變遷聯盟主席
日盛金控資深執行副總經理

學歷

舊金山金門大學財務銀行碩士
台灣大學大氣科學學士

蔡政哲 Jeffrey Tsai
資深合夥人

蔡政哲先生在資產管理、生物醫學和電子商務領域有超過20年的經驗，並創辦了多家成功企業，具豐富的管理經驗。他成立了富盛證券投顧，是安盛投資管理和先機環球投資台灣的總代理，受到金融機構和銀行的認可。

2001年，蔡政哲先生加入Hutchison-Priceline，擔任亞洲區總監，推動業務發展並在新加坡籌設了分公司。之前，他在台灣擔任飛利浦多媒體的專案負責人，負責市場開發。

在生物醫學方面，他於2016年創立了安瑞生醫，專注於細胞治療技術研發，並成為宜蘊生醫的創辦人，打造了華人生殖醫學的領先品牌。

在過去十年，他擔任了技嘉科技、遠雄人壽和佳龍科技的獨立董事，並主持各委員會，積極參與公司治理。

經歷

美兆生技董事長
宜蘊生醫總經理
富盛證券投顧執行董事
佳龍科技獨立董事
金盛元興業董事
安瑞生醫總經理
Hutchison-Priceline 亞洲區總監
飛利浦多媒體專案負責人
技嘉科技薪酬委員會委員
遠雄人壽前獨立董事

學歷

美國佩斯大學企管碩士
國立政治大學企業家經營管理研究班

Andrew Lin
Chairman / Managing Partner

Mr. Lin has nearly 40 years of experience in biotechnology, asset management, capital markets, and corporate governance. He serves as the Chairman of NUWA Biomedical, TaiRx Biotechnology, and BRIM Biotechnology, bringing extensive expertise in biotechnology. He has held senior positions at Lotus Pharmaceutical and Hasumi International Biotech.

He was formerly the President of J.P. Morgan Securities (Taiwan) Limited and became the first underwriter for a Hong Kong IPO between 2008 and 2009. He served as a Senior Partner at Hong Kong-based SAIF Eagle Fund. He is in senior positions at ABN AMRO, Chicony Chengdu International, and 源泰 Investment.

Mr. Lin has held senior positions in multiple listed companies, including Chairman, CEO, and General Manager, and has served on the board of directors for various companies such as Fubon Life Insurance, Crown Bioscience, EPISTAR, Lite-On IT Corporation, Silitech Technology Corporation, and 104 Corporation.

Experience

Chairman at TaiRx
Chairman at BRIM Biotechnology
Chairman at NUWA Biomedical
Independent Director at Fubon Life Insurance
Independent Director at Acerpure
Chairman at Lotus Pharmaceutical
CEO at Hasumi International
President at Macquarie Group Limited
CFO at Liteon Technology
CEO at J.P. Morgan Securities (Taiwan) Limited

Education

MBA from The University of Chicago
An M.S. in electrical and computer engineering from the University of Massachusetts at Amherst

Mark Wei
Senior Partner

Mr. Wei has 40 years of work experience. He began his career as a foreign trade officer at the Ministry of Economic Affairs, later becoming the Chief of the Securities and Exchange Commission at the Ministry of Finance, responsible for asset management and foreign investment liberalization. Subsequently, he served as the head of the International Department and Securities Issuance Department at the Securities and Futures Bureau, becoming highly knowledgeable about Taiwan's capital market regulations.

In 1999, he was appointed Deputy Director of the Insurance Bureau at the Ministry of Finance, later becoming the first Director of the Insurance Bureau at the Financial Supervisory Commission, serving for a total of 6 years. He resolved the crisis of interest rate spread losses in life insurance companies and promoted overseas investments and new insurance products in the industry.

In 2004, he became the first Taiwanese recipient of the prestigious Eisenhower Exchange Fellowships in the United States.

In 2005, he joined AIG Taiwan as Chairman, facilitating the acquisition of Central Insurance Company and making AIG the largest foreign investor at that time.

In 2010, he joined KGI Securities as Chairman, successfully guiding several biotech companies to go public. He later participated in the establishment of KGI Bank, focusing on the development of financial technology and bringing new vitality to Taiwan's financial industry.

Experience

Chairman at Shin Kong Financial Holding
Chairman at Shin Kong Life Insurance
Director at Ascendo Biotechnology
Independent Director at Nuvoton Tech
Chairman at KGI Bank
Chairman at KGI Securities
Chairman at AIG Securities (Taiwan)
Director-General of the Insurance Bureau, Financial Supervisory
Commission of the Executive Yuan
CEO at Taiwan Insurance Institute

Education

MBA from University of Washington
National Chiao Tung University Bachelor of Marine Transportation

Sophia Cheng
Senior Partner

Ms. Cheng currently serves as the Chief Investment Officer of Cathay Financial Holdings and is responsible for formulating investment and operational strategies for the Cathay Group. She previously was Chairman at Merrill Lynch Global Investment, overseeing the Taiwan research department and domestic financial management. With nearly thirty years of practical experience in the capital markets, she specializes in financial industry operational strategies and advocates for financial market reforms. She is highly respected for her research in banking, securities, and insurance industries, garnering attention from international investors and governments.

Ms. Cheng actively promotes Cathay Financial Holdings' participation in international climate change-related organizations and advocacy activities. She currently serves as the Chairperson of the Asian Investors' Climate Change Alliance, advocating for Asian institutional investors to focus on climate change issues. Over the years, she has been dedicated to corporate sustainable development, making significant contributions. In 2019, she was awarded the "Asia's Top Sustainability Superwomen" award and was named one of the "Global Top 50 Women in Asset Management" in 2021. In 2022, she was honored with the "Taiwan Outstanding Sustainable Figure Award."

Experience

CIO at Cathay Financial Holdings
Director at BRIM Biotechnology
Director at Ascendo Biotechnolog
Director at Genome Frontier Therapeutics
Consultant at Taiwan Executive Yuan
Advisor at National Development Council
Director at Taiwan M&A and Private Equity Council
Director at Taiwan Impact Investing Association
Chairman at Asia Investor Group on Climate Change
Vice President at Jih Sun Financial Holding

Education

Master of Finance and Banking from Golden Gate University, San Francisco
Bachelor of Atmospheric Sciences from National Taiwan University

Jeffrey Tsai
Senior Partner

Mr. Tsai has over 20 years of experience in asset management, biomedicine, and e-commerce fields, having founded multiple successful enterprises and possessing extensive management expertise. He established Capital Gateway Investments and serves as the general agent for AXA Investment Managers and Old Mutual Global Investors in Taiwan, recognized by financial institutions and banks.

In 2001, Mr. Tsai joined Hutchison-Priceline as the Director for the Asia-Pacific region, driving business development and establishing a subsidiary in Singapore. Previously, he served as the project manager for Philips Multimedia in Taiwan, overseeing market development.

In the field of biomedicine, he founded Ceres Biomedical in 2016, focusing on the research and development of cellular therapy techniques, and co-founded NUWA Biomedical, leading the development of the foremost brand in Chinese reproductive medicine.

Over the past decade, he has served as an independent director for companies such as GIGA-BYTE Technology, Farglory Life Insurance, and Super Dragon Technolog, chairing various committees and actively participating in corporate governance.

Experience

Chairman at Major Biotech
Executive Director at Capital Gateway Investments
CEO at NUWA Biomedical
Independent Director at Super Dragon Tech
Director at Glory Wheel Enterpris
CEO at Ceres Biomedical
Director at Hutchison-Priceline
Independent Director at Far Glory Life Insurance

Education

Master of Business Administration from Pace University, USA
Entrepreneurial Business Management Program at National Chengchi University

Ingrid Lai
Senior Manager

Ms. Lai currently serves as senior manager at Hui Li International, with over 5 years of buy-side experience in private equity investment and nearly 10 years of sell-side experience in investment banking. Before joining Hui Li International, she worked at a private equity fund, where she was responsible for target evaluation and M&A structuring. She has also worked at Cathay Securities and KGI Securities, leading or participating in more than 10 public market projects across various industries, including medical devices, electronics, information services, and retail, accumulating extensive relevant experience.

Ms. Lai holds a Master's degree in Accounting and Finance from the University of Illinois at Urbana-Champaign and is a certified public accountant in the state of Illinois.

Education

Master of Finance and Accounting from University of Illinois at Urbana-Champaign, USA

Amanda Kuang
Assistant Manager

Ms. Kuang currently serves as an assistant manager at Hui Li International. With 7 years of experiences in capital markets and financial consulting, she specializes in investment banking projects and M&A deals.
Before joining Hui Li International, she served in the transaction service department of KPMG Taiwan for 2.5 years, providing financial due diligence service for M&A and equity investment deals. The industries include manufacturing, finance, online education, electronic payment, food and fast food chains, etc. She also served in the investment banking department of IBF Securities and CTBC Securities for a total of 5 years, where she participated in IPOs of Ingentec and Thai Kin-KY, and SPOs such as Hiroca-KY and Fulgent Sun-KY.
Ms. Kuang holds a Master of Science in Banking and International Finance degree from Bayes Business School, City University of London, and a Bachelor in International Business from National Chengchi University.

Experience

Financial Consulting Assistant Manager at KPMG Deal Advisory Limited
Capital Market Department Counseling and Evaluation Assistant Manager at IBF Securities
Investment Banking Advisory specialist at CTBC Securities

Education

Master of Bayes Business School Banking and International Finance

INVEST

大健康一號

投資

林羣 Andrew Lin 董事長 / 管理合夥人

經歷

學歷

魏寶生 Mark Wei 資深合夥人

經歷

學歷

程淑芬 Sophia Cheng 資深合夥人

經歷

學歷

蔡政哲 Jeffrey Tsai 資深合夥人

經歷

學歷

蕭名何 Halu Hsiao 營運長

經歷

學歷

林庭寬 Martin Lin 投資部協理

賴雅暐 Ingrid Lai 投資部協理

學歷

葉育瀅 Annie Yeh 研究部協理

呂鈺萱 Sheryl Lu 投資部副理

經歷

學歷

Andrew Lin Chairman / Managing Partner

Experience

Education

Mark Wei Senior Partner

Experience

Education

Sophia Cheng Senior Partner

Experience

Education

Jeffrey Tsai Senior Partner

Experience

Education

Halu Hsiao COO

Experience

Education

Martin Lin Senior Manager

Ingrid Lai Senior Manager

Education

Annie Yeh Senior Manager, Research

Sheryl Lu Assistant Manager

Experience

Education

楊紹云 Diana Yang 執行秘書

經歷

學歷

Diana Yang Executive Secretary

Experience

Education

Amanda Kuang Assistant Manager

Experience

Education

匡小琪 Amanda Kuang 投資部副理

經歷

學歷

林羣 Andrew Lin
董事長 / 管理合夥人

魏寶生 Mark Wei
資深合夥人

程淑芬 Sophia Cheng
資深合夥人

蔡政哲 Jeffrey Tsai
資深合夥人

蕭名何 Halu Hsiao
營運長

林庭寬 Martin Lin
投資部協理

賴雅暐 Ingrid Lai
投資部協理

葉育瀅 Annie Yeh
研究部協理

呂鈺萱 Sheryl Lu
投資部副理

Andrew Lin
Chairman / Managing Partner

Mark Wei
Senior Partner

Sophia Cheng
Senior Partner

Jeffrey Tsai
Senior Partner

Halu Hsiao
COO

Martin Lin
Senior Manager

Ingrid Lai
Senior Manager

Annie Yeh
Senior Manager, Research

Sheryl Lu
Assistant Manager

楊紹云 Diana Yang
執行秘書

Diana Yang
Executive Secretary

Amanda Kuang
Assistant Manager

匡小琪 Amanda Kuang
投資部副理